Warning: Undefined array key "mm" in /www/wwwroot/www.ai-bt.com/si.php on line 10 Deprecated: trim(): Passing null to parameter #1 ($string) of type string is deprecated in /www/wwwroot/www.ai-bt.com/si.php on line 10 Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time.

Literature DB >> 30076822

Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time.

Zachary R McCaw¹, Ariela R Orkaby², Lee-Jen Wei¹, Dae Hyun Kim³, Michael W Rich⁴.

Abstract

Entities: Chemical

Mesh：

Year: 2018 PMID： 30076822 DOI： 10.1016/j.amjmed.2018.07.026

Source DB: PubMed Journal: Am J Med ISSN： 0002-9343 Impact factor: 5.928

Keyword Cloud
Cited

× No keyword cloud information.

7 in total

1. Trifluridine/tipiracil in metastatic gastric cancer.

Authors: Zachary R McCaw; Dae Hyun Kim; Lu Tian; Haoda Fu; Lee-Jen Wei
Journal: Lancet Oncol Date: 2019-01 Impact factor: 41.316

2. Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies.

Authors: Zachary R McCaw; Lu Tian; Jiawei Wei; Brian Lee Claggett; Frank Bretz; Garrett Fitzmaurice; Lee-Jen Wei
Journal: Stat Med Date: 2021-12-10 Impact factor: 2.373

3. Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial.

Authors: Dae Hyun Kim; Curtis Tatsuoka; Zhengyi Chen; Jackson T Wright; Michelle C Odden; Srinivasan Beddhu; Brandon K Bellows; Adam Bress; Thaddeus Carson; William C Cushman; Karen C Johnson; Donald E Morisky; Henry Punzi; Leonardo Tamariz; Song Yang; Lee-Jen Wei
Journal: J Gen Intern Med Date: 2022-08-09 Impact factor: 6.473

4. Efficacy and Safety of Intensive Blood Pressure Therapy Using Restricted Mean Survival Time-Insights from the SPRINT Trial.

Authors: Ashok Krishnaswami; Eric D Peterson; Dae Hyun Kim; Parag Goyal; Michael W Rich
Journal: Am J Med Date: 2020-02-13 Impact factor: 4.965

Applying Evidence-Based Medicine to Shared Decision Making: Value of Restricted MeanSurvival Time.

1. Trifluridine/tipiracil in metastatic gastric cancer.

2. Choosing clinically interpretable summary measures and robust analytic procedures for quantifying the treatment difference in comparative clinical studies.

3. Intensive Versus Standard Blood Pressure Lowering and Days Free of Cardiovascular Events and Serious Adverse Events: a Post Hoc Analysis of Systolic Blood Pressure Intervention Trial.

4. Efficacy and Safety of Intensive Blood Pressure Therapy Using Restricted Mean Survival Time-Insights from the SPRINT Trial.

5. Restricted mean survival time versus conventional measures for treatment decision-making.

Review 6. How to Quantify and Interpret Treatment Effects in Comparative Clinical Studies of COVID-19.

7. Utility of Restricted Mean Survival Time for Analyzing Time to Nursing Home Placement Among Patients With Dementia.